<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bioph</journal-id><journal-title-group><journal-title xml:lang="ru">Biomedical Photonics</journal-title><trans-title-group xml:lang="en"><trans-title>Biomedical Photonics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2413-9432</issn><publisher><publisher-name>Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24931/2413-9432-2020-9-2-29-35</article-id><article-id custom-type="elpub" pub-id-type="custom">bioph-424</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Транспупиллярная термотерапия меланомы сосудистой оболочки глаза</article-title><trans-title-group xml:lang="en"><trans-title>Transpupillary thermotherapy of choroidal melanoma</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Науменко</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Naumenko</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лесной, Республика Беларусь</p></bio><bio xml:lang="en"><p>Lesnoy, Belarus</p></bio><email xlink:type="simple">larisanau@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Республиканский научно-практический центр онкологии и медицинской радиологии им. Н.Н. Александрова<country>Беларусь</country></aff><aff xml:lang="en">N.N. Alexandrov National Cancer Center<country>Belarus</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>24</day><month>07</month><year>2020</year></pub-date><volume>9</volume><issue>2</issue><fpage>29</fpage><lpage>35</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Науменко Л.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Науменко Л.В.</copyright-holder><copyright-holder xml:lang="en">Naumenko L.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pdt-journal.com/jour/article/view/424">https://www.pdt-journal.com/jour/article/view/424</self-uri><abstract><p>Проведен ретроспективный анализ непосредственной и отдаленной эффективности лечения меланомы сосудистой оболочки глаза методом транспупиллярной термотерапии (ТТТ). Исследование включало 84 пациента с меланомой сосудистой оболочки глаза (C69.3), получивших лечение в период 2007–2018 гг. Выборка больных проведена из базы Белорусского канцер-регистра. Средние значения толщины опухоли составили 2,6±1,3 мм, диаметра основания – 7,2±3,3 мм. ТТТ проводили с использованием диодного лазера, длина волны 860 нм, мощность излучения 200 – 800 мВт, экспозиция 60 с, диаметр лазерного пятна от 1 до 3 мм. Термическому воздействию подвергали всю поверхность опухоли, поля располагали с перекрытием, от периферии к вершине опухоли. У 75 пациентов проведен один, у 9 – два сеанса ТТТ с интервалом 3 – 4 нед. В результате проведенного лечения у 51 (60,7%) пациента зарегистрирована полная резорбция опухоли, у 28 (33,3%) – стабилизация опухолевого процесса, у 5 (6,0%) – отсутствие эффекта от лечения. В группе пациентов со стабилизацией опухолевого процесса продолженный рост зафиксирован у 16 (19,1%) при сроках наблюдения от 3 мес до 4 лет. У 19 (37,3%) больных из группы с полной регрессией опухоли зарегистрирован рецидив заболевания на сроках от 1 до 8 лет наблюдения после проведения ТТТ. Метастатическая болезнь (прогрессирование заболевания) развилась у 5 (5,9%) пациентов, из них в течение первых 12 мес – у 1 больного, через 4 года – у 1, в сроки наблюдения более 5 лет – у 3. Анализ эффективности ТТТ в зависимости от размеров меланомы хориоидеи показал, что с увеличением толщины и диаметра основания опухолевого очага непосредственная эффективность снижается, а вероятность продолженного роста опухоли возрастает.</p></abstract><trans-abstract xml:lang="en"><p>A retrospective analysis of the immediate and long-term effectiveness of the treatment of the choroidal melanoma using transpupillary thermotherapy (TTT) was carried out. The study included 84 patients with choroidal melanoma (C69.3) who received treatment between 2007 and 2018. Patients were sampled from the Belarusian Cancer Register. The average values of the thickness of the tumor were 2.6±1.3 mm, the diameter of the base - 7.2±3.3 mm. TTT was carried out using a diode laser with a wavelength of 860 nm and radiation power of 200 - 800 mW, the exposure time was 60 s, and the diameter of the laser spot was varied between 1 and 3 mm. The entire surface of the tumor was thermally treated with overlapping fields from the periphery to the top. 75 patients underwent a single session of TTT, while 9 - two sessions with an interval of 3–4 weeks. As a result of the treatment, 51 (60.7%) patients showed complete tumor resorption, 28 (33.3%) patients had stabilization of the tumor process, and 5 (6.0%) patients had no effect. In the group of patients with stabilization of the tumor process, continued growth was recorded in 16 (19.1%) patients with follow-up periods of 3 months to 4 years. In 19 (37.3%) patients from the group with complete tumor regression, relapse was observed 1 to 8 years after TTT. Metastatic disease (disease progression) developed in 5 (5.9%) patients, of which in 1 patient during the first 12 months, in 1 patient - after 4 years, and in 3 patients more than after 5 years of the follow-up observation. Analysis of the effectiveness of TTT of choroidal melanoma showed that an increase in the thickness and diameter of the base of the tumor focus results in the decrease of immediate effectiveness, and the rise of the likelihood of continued tumor growth.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>меланома хориоидеи</kwd><kwd>транспупиллярная термотерапия</kwd><kwd>фотодинамическая терапия</kwd><kwd>брахитерапия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>choroidal melanoma</kwd><kwd>transpupillary thermotherapy</kwd><kwd>photodynamic therapy</kwd><kwd>brachytherapy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Океанов А. Е., Моисеев П. И., Левин Л. Ф. и соавт. Статистика онкологических заболеваний в Республике Беларусь (2008–2018): Белорусский канцер-регистр/под ред. О. Г. Суконко. – Минск: Республиканский научно-практический центр онкологии и медицинской радиологии им. Н. Н. Александрова, 2018. – 286 с.</mixed-citation><mixed-citation xml:lang="en">Okeanov A. E., Moiseyev P. I., Levin L. F. et al. Statistika onkologicheskih zabolevaniy v Resbublike Belarus (2008–2018): Belarusian kantserregistr [Statistics of cancer diseases in the Republic of Belarus (2008– 2017): Belarusian Cancer Registry]. Ed. O. G. Sukonko. Minsk, N. N. Alexandrov National Cancer Centre of Belarus, 2018. 286 p.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Науменко Л. В., Жиляева Е. П. Алгоритмы диагностики и лечения злокачественных новообразований: клинический протокол/под ред. О. Г. Суконко, С. А. Красного.– Минск: Профессиональные издания, ч. 63, 2019. – С. 493–509.</mixed-citation><mixed-citation xml:lang="en">Naumenko L. V., Zhilyaeva E. P. Algoritmi diagnostiki i lecheniya zlokachestvennyh novoobrazovaniy: klinicheskiy protocol [Algorithms for the diagnosis and treatment of malignant neoplasms: a clinical protocol]. Ed. O. G. Sukonko. S. A. Krasny. Minsk, Professional editions, ch. 63, 2019. pp. 493–509.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Shields C. L., Shields J. A., Perez N. et al. Primary transpupillary thermotherapy for choroidal melanoma in 256 consecutive cases. Outcomes and limitations//Ophthalmology. – 2002. – Vol. 109 (2). – P. 225–234.</mixed-citation><mixed-citation xml:lang="en">Shields C. L., Shields J. A., Perez N., Singh A. D., Cater J. Primary transpupillary thermotherapy for choroidal melanoma in 256 consecutive cases. Outcomes and limitations. Ophthalmology, 2002, vol. 109 (2), pp. 225–234.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Houston S. K., Wykoff C. C., Berrocal A. M. et al. Lasers for the treatment of intraocular tumors//Lasers Med Sci.– 2013. – Vol. 28 (3). – P. 1025–1034.</mixed-citation><mixed-citation xml:lang="en">Houston S. K., Wykoff C. C., Berrocal A. M., Hess D. J., Murray T. G. Lasers for the treatment of intraocular tumors. Lasers Med Sci, 2013, vol. 28 (3), pp. 1025–1034.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Rishi P., Koundanya V. V., Shields C. L. Using risk factors for detection and prognostication of uveal melanoma//Indian J Ophthalmol. – 2015. – Vol. 63 (2). – P. 110‐116. doi:10.4103/0301– 4738.154373</mixed-citation><mixed-citation xml:lang="en">Rishi P., Koundanya V. V., Shields C. L. Using risk factors for detection and prognostication of uveal melanoma. Indian J Ophthalmol, 2015, vol. 63 (2), pp. 110‐116. doi:10.4103/0301–4738.154373</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mashayekhi A., Shields C. L., Rishi P. et al. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control//Ophthalmology. – 2015. –Vol. 122 (3). – P. 600–609.</mixed-citation><mixed-citation xml:lang="en">Mashayekhi A., Shields C. L., Rishi P., Atalay H. T., Pellegrini M., McLaughlin J. P., Patrick K. A., Morton S. J., Remmer M. H., Parendo A., Schlitt M. A., Shields J. A. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control. Ophthalmology, 2015, vol. 122 (3), pp. 600–609.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Turcotte S., Bergeron D., Rousseau A. P. et al. Primary transpupillary thermotherapy for choroidalindeterminatemelanocyticlesions// CanJOphthalmol.–2014.–Vol.49 (5).– P. 464–467.</mixed-citation><mixed-citation xml:lang="en">Turcotte S., Bergeron D., Rousseau A. P., Mouriaux F. Primary transpupillary thermotherapy for choroidal in determinate melanocytic lesions. Can J Ophthalmol, 2014, vol. 49 (5), pp. 464–467.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chojniak M. M., Chojniak R., Nishimoto I. N. et al. Primary transpupillary thermotherapy for small choroidal melanoma//Graefes Arch Clin Exp Ophthalmol.– 2011. –Vol. 249 (12). – P. 1859–1865.</mixed-citation><mixed-citation xml:lang="en">Chojniak M. M., Chojniak R., Nishimoto I. N., Allemann N., Erwenne C. M. Primary transpupillary thermotherapy for small choroidal. Graefes Arch Clin Exp Ophthalmol, 2011, vol. 249 (12), pp. 1859–1865.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Stoffelns B. M., Schoepfer K., Vetter J. et al. Long-term follow-up 10 years after transpupillary thermotherapy (TTT) for small, posterior located malignant melanomas of the choroid//Klin Monbl Augenheilkd. – 2011. – Vol. 228 (4). – P. 277–283.</mixed-citation><mixed-citation xml:lang="en">Stoffelns B. M., Schoepfer K., Vetter J., Mirshahi A., Elflein H. Longterm follow-up 10 years after transpupillary thermotherapy (TTT) for small, posterior located malignant melanomas of the choroid. Klin Monbl Augenheilkd, 2011, vol. 228 (4), pp. 277–283.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Yarovoy A. A., Magaramov D. A., Bulgakova E. S. Which choroidal melanoma should be treated with primary transpupillary thermotherapy? Ourexperience from 78 patients//Eur J Ophthalmol.– 2010.– Vol. 20 (1).– P. 186–193.</mixed-citation><mixed-citation xml:lang="en">Yarovoy A. A., Magaramov D. A., Bulgakova E. S. Which choroidal melanoma should be treated with primary transpupillary thermotherapy? Our experience from 78 patients. Eur J Ophthalmol, 2010, vol. 20 (1), pp. 186–193.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gündüz K., Karslioğlu M. Z., Köse K. Primary transpupillary thermotherapy of choroidal melanocytic lesions//Middle East Afr J Ophthalmol.– 2011. – Vol. 18 (2). – P. 183–188.</mixed-citation><mixed-citation xml:lang="en">Gündüz K., Karslioğlu M. Z., Köse K. Primary transpupillary thermotherapy of choroidal melanocytic lesions. Middle East Afr J Ophthalmol, 2011, vol. 18 (2), pp. 183–188.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Caminal J. M., Mejia-Castillo K. A., Arias L. et al. Subthreshold transpupillary thermotherapy in management of foveal subretinal fluid in small pigmented choroidal lesions//Retina. – 2013. – Vol. 33 (1). – P. 194–199.</mixed-citation><mixed-citation xml:lang="en">Caminal J. M., Mejia-Castillo K. A., Arias L., Catala J., Rubio M., Garcia P., Pujol O., Arruga J. Subthreshold transpupillary thermotherapy in management of foveal subretinal fluid in small pigmented choroidal lesions. Retina, 2013, vol. 33 (1), pp. 194–199.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Бровкина А. Ф., Борисова З. Л. Оптимизация показате- лей транспупиллярной термотерапии меланомы хориои- деи//Вестник Офтальмологии. – 2010. – Т. 126, № 4. – С. 48–52 (in Russian).</mixed-citation><mixed-citation xml:lang="en">Brovkina A. F., Borisova Z. L. Optimization of indications for transpupillary thermotherapy in choroidal melanomas. Vestnik Oftal’mologii, 2010, vol. 126 (4), pp. 48–52. (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Stoffelns B. M., Schoepfer K., Jochem T., et al. Tumor regression in malignant choroidal melanomas after transpupillary thermotherapy (TTT) versus ruthenium brachytherapy and sandwich therapy – a comparative analysis//Klin Monbl Augenheilkd.– 2010. – Vol. 227 (4). – P. 262–268.</mixed-citation><mixed-citation xml:lang="en">Stoffelns B. M., Schoepfer K., Jochem T., Faldum A. Tumor regression in malignant choroidal melanomas after transpupillary thermotherapy (TTT) versus ruthenium brachytherapy and sandwich therapy – acomparativeanalysis. Klin Monbl Augenheilkd, 2010, vol. 227 (4), pp. 262–268. (in German)</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
